This webinar jointly organized by PASCV and ESCV will discuss the epidemiology and pathogenesis of EV-D68 and discuss different practices for the diagnosis and surveillance of EV-D68 across Europe, the United States and Latin America.
Registration
Registration is free for all members and non-members. Registration is non-transferable. Register here
Continuing Education
PASCV is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E ® Program. This webinar offers 1.0 ASCLS P.A.C.E.® contact hour. Click here for more information on continuing education.
Description
Since being first isolated six decades ago, enterovirus D68 (EV-D68), a member of the Picornaviridae family, has led to multiple outbreaks around the world and is believed to be associated with acute flaccid myelitis. However, there are still unmet gaps in diagnosis and surveillance of EV-D68. This webinar jointly organized by PASCV and ESCV will discuss the epidemiology and pathogenesis of EV-D68 and discuss different practices for the diagnosis and surveillance of EV-D68 across Europe, the United States and Latin America.
Learning Objectives
- Recognize infections due to enterovirus D68
- Compare global diagnosis and surveillance practice of enterovirus D68
- Identify challenges and opportunities for diagnosis and control of enterovirus D68
Moderators
Catherine Moore, PhD
Consultant Clinical Scientist Virology, Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, Wales, UK
Benjamin M. Liu, MBBS, PhD, D(ABMM), MB(ASCP)
Assistant Director, Medical Microbiology and Infectious Disease Molecular Diagnostics Laboratory, Children’s National Hospital, Washington, DC, USA
Speakers
Benjamin Pinsky, MD, PhD
Director, Clinical Virology Laboratory, Stanford Health Care and Stanford Children’s Health, Palo Alto, CA, USA
Pam Vallely
Professor of Medical Virology, University of Manchester, Manchester, England, UK
Heli J. Harvala
Consultant Medical Virologist, NHS Blood and Transplant, London, England, UK
Rangaraj Selvarangan, PhD, BVSc, DABMM, FIDSA, FAAM
Director, Emerging Infections, Children’s Mercy Research Institute, Kansas City, MO, USA
Thea Kølsen Fischer
Professor, University of Copenhagen, Copenhagen, Denmark
Kevin Messacar, MD, PhD
Associate Professor of Pediatrics, Children’s Hospital Colorado, Aurora, CO, USA